TABLE 2.
Performance Characteristics of Models Predicting 9 Cost and Utilization Outcomes
|
Individual-Level R2
(N=456,781) |
Practice-Level (N=436) Grouped R2 Predictions |
||||
|---|---|---|---|---|---|
|
| |||||
| Mean (Std. Dev) |
Generic (RRS0) |
Tailored (RRSi) |
Generic (RRS0) |
Tailored (RRSi) |
|
| Total health spending, in dollars (Y0)* |
3,781 (12,113) |
42% | 42% | 78% | 78% |
| Total prescription drug spending, in dollars* | 836 (1,937) |
19% | 37% | 69% | 86% |
| Number of prescriptions for antibiotics of concern |
0.57 (1.12) |
3% | 29% | 5% | 47% |
| Number of prescriptions for antibiotics | 1.06 (1.69) |
4% | 32% | 6% | 56% |
| Hospital admissions, all types | 0.058 (0.276) |
13% | 53% | 39% | 64% |
| Hospital admissions, not related to childbirth, pregnancy, or behavioral health |
0.035 (0.224) |
19% | 43% | 66% | 76% |
| Hospital admissions for ambulatory-caresensitive conditions |
0.004 (0.067) |
4% | 19% | 14% | 41% |
| Advanced imaging tests in relative value units (RVUs) |
3.17 (11.04) |
25% | 46% | 65% | 79% |
| Emergency department visits | 0.18 (0.54) |
3% | 25% | 0% | 17% |